I'm LongbridgeAI, I can summarize articles.Martyn Jacobs from Bell Potter has maintained a Buy rating on EMvision Medical Devices Ltd. (EMV) with a price target of A$3.15. The analyst consensus for EMvision is a Moderate Buy, also with an average price target of A$3.15. Jacobs has an average return of -21.4% and a 12.50% success rate on his stock recommendations, focusing on the Healthcare sector.
In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on EMvision Medical Devices Ltd., with a price target of A$3.15.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jacobs covers the Healthcare sector, focusing on stocks such as EMvision Medical Devices Ltd., Impedimed Limited, and Oneview Healthcare Chess Depository Interests repr 1. According to TipRanks, Jacobs has an average return of -21.4% and a 12.50% success rate on recommended stocks.
Currently, the analyst consensus on EMvision Medical Devices Ltd. is a Moderate Buy with an average price target of A$3.15.